FDA Inspection 1242998 — Newpharma, Inc.
The FDA completed an inspection of Newpharma, Inc. on July 1, 2024 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 1, 2024
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Miami, FL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 15571 | 21 CFR 111.153 | Written procedures - packaging |
| 15940 | 21 CFR 111.105(h) | Quality control - production, process control |
| 15963 | 21 CFR 111.113(b)(2) | Quality control - reject; specification not met |